Home › Compare › NXSCF vs FCPT

NXSCF vs FCPT: Dividend Comparison 2026

NXSCF yields 10095.00% · FCPT yields 6.05%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 NXSCF wins by $60522276252191552.00M in total portfolio value
10 years
NXSCF
NXSCF
● Live price
10095.00%
Share price
$0.00
Annual div
$0.10
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$60522276252191552.00M
Annual income
$59,365,457,623,754,850,000,000.00
Full NXSCF calculator →
FCPT
FCPT
● Live price
6.05%
Share price
$23.65
Annual div
$1.43
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.1K
Annual income
$5,775.28
Full FCPT calculator →

Portfolio growth — NXSCF vs FCPT

📍 NXSCF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNXSCFFCPT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NXSCF + FCPT cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
NXSCF pays
FCPT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NXSCF
Annual income on $10K today (after 15% tax)
$858,075.00/yr
After 10yr DRIP, annual income (after tax)
$50,460,638,980,191,620,000,000.00/yr
FCPT
Annual income on $10K today (after 15% tax)
$514.49/yr
After 10yr DRIP, annual income (after tax)
$4,908.99/yr
At 15% tax rate, NXSCF beats the other by $50,460,638,980,191,620,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NXSCF + FCPT for your $10,000?

NXSCF: 50%FCPT: 50%
100% FCPT50/50100% NXSCF
Portfolio after 10yr
$30261138126095776.00M
Annual income
$29,682,728,811,877,424,000,000.00/yr
Blended yield
98.09%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on FCPT right now

NXSCF
No analyst data
Altman Z
-16.5
Piotroski
4/9
FCPT
Analyst Ratings
5
Buy
10
Hold
Consensus: Hold
Price Target
$27.00
+14.2% upside vs current
Range: $25.00 — $29.00
Altman Z
1.4
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NXSCF buys
0
FCPT buys
0
No recent congressional trades found for NXSCF or FCPT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNXSCFFCPT
Forward yield10095.00% ✓6.05%
Annual dividend / share$0.10$1.43 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$60522276252191552.00M ✓$49.1K
Annual income after 10y$59,365,457,623,754,850,000,000.00 ✓$5,775.28
Total dividends collected$60445311406050536.00M ✓$24.1K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: NXSCF vs FCPT ($10,000, DRIP)

YearNXSCF PortfolioNXSCF Income/yrFCPT PortfolioFCPT Income/yrGap
1← crossover$1,020,200$1,009,500.00$11,401$700.92+$1.01M → NXSCF
2$97,343,193$96,251,579.44$13,064$864.84+$97.33M → NXSCF
3$8,687,260,875$8,583,103,657.69$15,051$1,072.48+$8687.25M → NXSCF
4$725,171,452,913$715,876,083,776.83$17,442$1,337.22+$725171.44M → NXSCF
5$56,624,484,726,557$55,848,551,271,940.71$20,340$1,677.08+$56624484.71M → NXSCF
6$4,136,189,552,978,259$4,075,601,354,320,842.00$23,880$2,116.57+$4136189552.95M → NXSCF
7$282,655,809,165,117,900$278,230,086,343,431,170.00$28,241$2,689.36+$282655809165.09M → NXSCF
8$18,072,047,576,372,183,000$17,769,605,860,565,506,000.00$33,660$3,442.07+$18072047576372.15M → NXSCF
9$1,081,138,905,081,034,700,000$1,061,801,814,174,316,400,000.00$40,456$4,439.95+$1081138905081034.75M → NXSCF
10$60,522,276,252,191,556,000,000$59,365,457,623,754,850,000,000.00$49,063$5,775.28+$60522276252191552.00M → NXSCF

NXSCF vs FCPT: Complete Analysis 2026

NXSCF — Stock

Next Science Limited, a medical technology company, researches, develops, and commercializes technologies that address the impacts of biofilms in human health in the United States and Australia. The company develops its products using Xbio Technology platform. It offers SURGX, an antimicrobial gel designed for surgical infection management; BACTISURE, a wound lavage that is used to remove biofilm; BlastX, an antimicrobial wound gel that destroys bacteria within the gel and defends from recolonization while maintaining a moist wound environment; and XPERIENCE, an no rinse antimicrobial solution that helps prevent surgical site infections. Next Science Limited was founded in 2012 and is headquartered in Chatswood, Australia.

Full NXSCF Calculator →

FCPT — REIT

FCPT, headquartered in Mill Valley, CA, is a real estate investment trust primarily engaged in the acquisition and leasing of restaurant properties. The Company seeks to grow its portfolio by acquiring additional real estate to lease, on a net basis, for use in the restaurant and retail industries.

Full FCPT Calculator →
📬

Get this NXSCF vs FCPT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NXSCF vs SCHDNXSCF vs JEPINXSCF vs ONXSCF vs KONXSCF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.